iLine S to fit with Cell Production Platform

Microscopy company Ovizio Imaging Systems, specialists in automated cell culture monitoring systems and Pall Life Sciences, a global leader in biopharmaceutical fluid management, have signed a long term global supply agreement for the iLine S microscope. The financial terms of the agreement have not been disclosed.

Ovizio has collaborated with Pall for several years to customise the iLine S microscope which will be commercialised as part of Pall’s Xpansion® cell production platform; a fully-closed bioreactor for large-scale production of adherent stem cells.

 “With the iLine S quantitative microscope, our customers will now benefit from automated production supervision, reduced production costs and accurate, efficient cell culture monitoring,” said Mario Philips, president of Single-Use Technologies at Pall Life Sciences.

 “This agreement strengthens our long-standing relationship with Pall Life Sciences. We are happy to continue the partnership. The agreement reinforces our position as leaders in the quantitative cell imaging market,” said Philip Mathuis, CEO of Ovizio. “We are working in close partnership with Pall to develop the next generation of microscopes to take cell therapy technology to the next level.”